Cardax, Inc. (CDXI)
OTCMKTS · Delayed Price · Currency is USD
0.0001
-0.0039 (-97.50%)
At close: Sep 24, 2025
Cardax Revenue
Cardax had revenue of $104.57K in the quarter ending March 31, 2021, a decrease of -26.78%. This brings the company's revenue in the last twelve months to $500.71K, down -27.31% year-over-year. In the year 2020, Cardax had annual revenue of $538.95K, down -24.19%.
Revenue (ttm)
500.71K
Revenue Growth
-27.31%
P/S Ratio
0.00
Revenue / Employee
45.52K
Employees
12
Market Cap
83.00
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2020 | 538.95K | -172.00K | -24.19% |
Dec 31, 2019 | 710.95K | -799.93K | -52.94% |
Dec 31, 2018 | 1.51M | 900.55K | 147.55% |
Dec 31, 2017 | 610.32K | 575.07K | 1,631.02% |
Dec 31, 2016 | 35.26K | - | - |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
American Oncology Network | 1.76B |
Veradigm | 588.02M |
Jushi Holdings | 256.36M |
Glass House Brands | 221.55M |
Elite Pharmaceuticals | 105.45M |
Silence Therapeutics | 27.17M |
Nuo Therapeutics | 1.95M |
Northwest Biotherapeutics | 1.09M |